2011
DOI: 10.1074/jbc.m111.277814
|View full text |Cite
|
Sign up to set email alerts
|

N-Acetylglucosamine Inhibits T-helper 1 (Th1)/T-helper 17 (Th17) Cell Responses and Treats Experimental Autoimmune Encephalomyelitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
91
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 100 publications
(97 citation statements)
references
References 41 publications
(56 reference statements)
6
91
0
Order By: Relevance
“…Recently it was shown that the monosaccharide N-acetylglucosamine, a component of HA, effectively inhibited T-cell activation and ameliorated MOG induced C57BL/6 EAE. However, treatment is clinically ineffective if EAE is induced in 2D2 T-cell receptor transgenic mice, which display more robust disease (53). The severity of EAE disease is known to vary depending on the population of cellular infiltrates.…”
Section: Discussionmentioning
confidence: 99%
“…Recently it was shown that the monosaccharide N-acetylglucosamine, a component of HA, effectively inhibited T-cell activation and ameliorated MOG induced C57BL/6 EAE. However, treatment is clinically ineffective if EAE is induced in 2D2 T-cell receptor transgenic mice, which display more robust disease (53). The severity of EAE disease is known to vary depending on the population of cellular infiltrates.…”
Section: Discussionmentioning
confidence: 99%
“…ÏȘ/ÏȘ Mice-GlcNAc supplementation in the drinking water of mice increases N-glycan branching on T cell receptors and regulates sensitivity to autoimmune antigens (49). Therefore, we tested whether GlcNAc in the drinking water (0.5 mg/ml) could increase Gcgr sensitivity.…”
Section: Glcnac Supplementation Rescues Sensitivity To Glucagon In Mgat5mentioning
confidence: 99%
“…They show potential reactions but do not reflect contributions of different sources to convergent pathways, cell and organ preferences, or allowance for metabolic states. Glycosylation disorders and models of these diseases are adding unexpected dimensions to the two-dimensional pathways (10,(37)(38)(39).…”
Section: Rediscovering Sugar Metabolismmentioning
confidence: 99%